TherapeuticsMD (TXMD) Gross Profit Growth (5y) (2016 - 2023)
TherapeuticsMD (TXMD) Gross Profit Growth (5y) (2016 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn |
| 10 | TherapeuticsMD | 280,418.39 | -8.14 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | -34.42% |
| Sep 30, 2023 | -15.09% |
| Jun 30, 2023 | -33.30% |
| Mar 31, 2023 | -33.25% |
| Dec 31, 2022 | 81.00% |
| Mar 31, 2022 | 34.19% |
| Dec 31, 2021 | 29.84% |
| Sep 30, 2021 | 36.17% |
| Jun 30, 2021 | 41.96% |
| Mar 31, 2021 | 31.76% |
| Dec 31, 2020 | 31.06% |
| Sep 30, 2020 | 32.08% |
| Jun 30, 2020 | 10.56% |
| Mar 31, 2020 | 22.68% |
| Dec 31, 2019 | 30.99% |
| Sep 30, 2019 | 48.18% |
| Jun 30, 2019 | 11.06% |
| Mar 31, 2019 | 9.75% |
| Dec 31, 2018 | 344.10% |
| Sep 30, 2018 | 341.94% |